Follicle-stimulating hormone (FSH) is a glycoprotein hormone that plays a key role in the regulation of gonadal functions in vertebrates. The present study reports the monitoring of pituitary and plasma Fsh levels during sex differentiation and oogenesis in European sea bass (Dicentrarchus labrax) using a homologous immunoassay and an in vitro bioassay. Both assays were used complementarily for the first time in a fish species. High levels of Fsh bioactivity in plasma were found during the initial phases of sexual differentiation. Plasma and pituitary Fsh (quantity and bioactivity) levels and biological to immunological (B:I) ratios were higher in females than in males, suggesting sexual dimorphism in the synthesis and potency of Fsh. In females, the B:I ratios in adult were lower than during sex differentiation indicating that Fsh would be less biopotent in the adult stage. Plasma Fsh bioactivity levels increased during vitellogenesis, suggesting that Fsh would be involved in the regulation of the midphases of oogenesis, whereas luteinizing hormone would be responsible for the final events.
INTRODUCTION
The gonadotropins (GTHs), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) are heterodimeric glycoproteins synthesized and secreted by the pituitary gland. The GTHs are formed by the noncovalent association of a common alpha subunit (CGA) with distinct beta subunits (FSHB and LHB) that confer hormone specificity [1, 2] . Both GTHs are essential in the endocrine control of vertebrate reproduction by regulating gonadal steroidogenesis and gametogenesis through the specific interactions with their respective receptors, LH receptor (LHR) and FSH receptor (FSHR). In most teleost orders, the functional duality between Fsh and Lh in critical moments of the reproductive life cycle, such as sex differentiation, puberty, or gametogenesis, has not yet been clarified adequately despite the recognized importance of the two GTHs in reproduction. This is caused primarily by the lack of appropriate tools for measuring fish GTHs, especially assays for the determination of Fsh levels.
Among teleosts, homologous immunoassays for Fsh have been developed only in three fish species with synchronous ovarian development, the chum salmon (Oncorhynchus keta) [3] coho salmon (Oncorhynchus kisutch) [4, 5] and rainbow trout (Oncorhynchus mykiss) [6, 7] , and one with an asynchronous ovarian development, the tilapia (Oreochromis niloticus) [8] . In other fish species, such quantitative tools have been restricted to Lh, a fact that hampered studies on the functional duality of Fsh and Lh in fish. Results obtained so far indicate that in salmonids Fsh regulates the early phases of gametogenesis, such as vitellogenesis and spermatogenesis, whereas Lh is responsible for the late phases, such as oocyte maturation, ovulation, and spermiation [9] . Nevertheless, in tilapia, the only nonsalmonid species studied so far, a concomitant increase of Fsh and Lh levels was observed during the vitellogenic phase, suggesting that in this perciform species Lh may play a role not only during oocyte maturation, but also at vitellogenesis [8] .
A few studies have also focused on the role of GTHs during sex differentiation. The endocrine control of sex differentiation involves a communication between the brain, pituitary, and gonad through the production of GTHs and steroids [10] . The GTHs have been shown to play a critical role in sex differentiation both in gonochoristic and hermaphroditic fishes [11] [12] [13] , but the underlying mechanisms behind these observations remain largely unknown. A variation in the chronological appearance of pituitary Fsh and Lh cells during sex differentiation has been reported in several teleost species [12, [14] [15] [16] [17] . Furthermore, sexually dimorphic expression of fshb was found in the hermaphrodite teleost honeycomb grouper (Epinephelus merra), suggesting that Fsh may trigger sex reversal in this species [11] .
The European sea bass (Dicentrarchus labrax) is a perciform fish used in both applied and basic studies because of its high commercial value and the large number of molecular and physiological tools available for the study of its reproductive process. This marine fish has a group-synchronous type of ovarian development [18] , and the role of Fsh during sex differentiation and the reproductive cycle are still not well clarified. Studies performed in the last few years have allowed the elucidation of some physiological and biochemical aspects of Fsh actions in this species. For example, expression analysis of the genes coding for the GTH subunits [19] and the enzyme cytochrome P450 aromatase (Cyp19a1, previously known as P450aromA) [20] during sex differentiation suggested a role of Fsh during this period. Studies with European sea bass Fsh demonstrated a high specificity in the activation of its cognate receptor in a dose-dependent manner and its ability to stimulate the production of sex steroids by in vitro culture of the gonads [21, 22] . However, while in females both GTHs were equally potent in stimulating 17b-estradiol (E2) secretion, in males Lh seemed to be more potent than Fsh in stimulating 11-ketotestosterone production. Analysis of seasonal expression of European sea bass fshr and lhr in sexually mature females revealed that the maximum fshr expression occurred before (late and postvitellogenesis) the maximum lhr expression (oocyte maturation and ovulation). A positive relationship was observed between ovarian levels of fshr mRNA and cyp19a1 mRNA and those of plasma E2, and of lhr mRNA and Lh plasma levels [23] . However, in order to clarify how Fsh modulates gonadal functions, knowledge about the kinetics of the levels of this hormone in the pituitary and plasma is imperative, but this information is still lacking for the European sea bass as well as for most fish species.
Different types of assays have been developed for the measurement of FSH in various animals. These methods can be grouped in assays that determine a response of a biological system to stimulation with FSH (e.g., bioassays, both in vivo and in vitro) and assays that estimate high affinity binding to molecules that exhibit specific properties of molecular recognition (e.g., immunoassays). In contrast to the former, these latter assays are intended to measure the number of molecules or their mass. However, bioassays are an ideal means to determine the functional aspects of GTHs. Since the pituitary glycoproteins are highly heterogeneous in terms of carbohydrate composition, the bioactivity of the different isoforms present in the pituitary and blood may vary greatly and does not always match their immunoreactivity [24, 25] . Since the early 1990s, a new generation of bioassays based on cell lines expressing the FSHR gene has emerged as a tool to measure serum FSH in mammalian species [26] [27] [28] [29] [30] .
Based on the above information, the objective of the present study was to develop methods to measure both bioactivity and quantity of Fsh in this important European aquaculture and fish reproduction research species, and to generate new information on its role in the process of sex differentiation and control of the reproductive cycle of European sea bass.
MATERIALS AND METHODS

Experimental Animals and Sample Collection
Two sibling populations of European sea bass, one of very small fish (predominantly males) and another of very large fish (predominantly females) were generated by four sequential size gradings during the period between 66 and 223 days posthatching (dph) [31] . At each grading, the fish were split approximately in a 50:50 ratio into large and small populations. After the first grading, the large fish from the large population and the small fish from the small population were kept. Since the eventual very small and very large populations consisted of 70% males and 96% females, respectively, these populations in the present study were referred to as males and females. Samples were collected from both populations every 50 days from 150 to 300 dph, and 6 pituitaries and 10 plasma samples per sampling point were analyzed. The body weight and total length (mean 6 SD) at 150 dph were 6.6 6 0.24 g and 85.1 6 0.96 mm in males, respectively, and 9.3 6 0.24 g and 96.3 6 0.76 mm in females, respectively. At 300 dph, males weighed 66.7 6 0.93 g and were 180.3 6 0.72 mm, respectively, while females weighed 130.9 6 1.75 g and were 218.8 6 0.75 mm, respectively.
Sexually mature females maintained in Torre la Sal, Spain (408NL), were sampled monthly during their first reproductive period, which generally occurs during the third year of life. For each pituitary and blood collection, five fish were anesthetized and killed in accordance with the Spanish legislation concerning the protection of animals used for experimentation or other scientific purposes. Blood was collected by caudal puncture with heparinized syringes and centrifuged (3000 3 g for 30 min at 48C). The upper plasma layer was separated and stored at À208C until use. Pituitary glands were collected, immediately frozen in liquid nitrogen, and stored at À808C. For analysis, individual pituitaries were homogenized mechanically in TBS-T (10 mM Tris base, 150 mM NaCl, and 0.05% Tween-20) using sterile syringes. The extract was centrifuged (3000 3 g for 15 min at 48C) to eliminate debris and stored at À808C until assayed. The stages of ovarian development were classified by light microscopy as in Rocha et al. [23] , following previously established criteria [32] : previtellogenesis (prevtg), early vitellogenesis (evtg), late vitellogenesis and postvitellogenesis (lvtg-pvtg), maturation and ovulation (mat-ovul), and atresia (atre).
Biological Activity Determinations for European Sea Bass Fsh
In order to determine bioactive Fsh, an in vitro bioassay was developed. The biological activity of Fsh in pituitary and plasma samples was analyzed using a human embryonic kidney (HEK) 293 cell line stably expressing the European sea bass Fsh receptor (sbsFshr) and the firefly luciferase reporter gene under the control of a promoter with cyclic adenosine 3 0 ,5 0 -monophosphate (cAMP)-responsive elements (CRE) binding sites (pCRE-LUC) [33] . The HEK 293 cells were grown at 378C in DMEM medium (Invitrogen) supplemented with 10% foetal bovine serum, 100 U (units) ml À1 penicillin, and 100 lg ml À1 streptomycin (Invitrogen) in a humidified incubator supplied with 5% CO 2 . Receptor activation by FSH was indirectly measured by recording changes in luciferase activity promoted by a rise of cAMP. Cells from the sbsFshr/pCRE-LUC HEK293 stable clone were seeded in 96-well cell culture plates (Corning) at a density of 4.5 3 10 5 cells well À1 in 300 ll of growth medium. After 16-20 h, medium was removed and cells were incubated with 100 ll of FSH standards or sample preparations per well (1/25 plasma; 1/ 2000-1/12 000 pituitary extract) in OPTIMEM or Advanced-DMEM media (Invitrogen) supplemented with 1% glutamine, 100 U ml À1 penicillin, and 100 lg ml À1 streptomycin. After a 6 h incubation, luciferase activity was directly quantified on the plates using the Steady-Glo Luciferase Assay System (Promega) and the ULTRA Evolution (Tecan) detection platform. All the samples were measured in triplicate, and the light emitted was expressed as relative lights units (RLU). Known quantities of recombinant European sea bass Fsh dimer produced in Chinese hamster ovary cells (CHO-scFsh) or insect cells (Sf9-Fsh) [22] were used to generate the standard curve. After logarithmic transformation, the standard curve was linearized, and a concentration could be extrapolated for each sample analyzed.
Plasma Lh and Fsh Extraction by Lectin
Extraction of plasma Fsh and Lh was performed by affinity chromatography with concanavalin A (Con A) Sepharose 4B (GE Healthcare). Briefly, a column with 1 ml of Con A Sheparose was equilibrated with 20 mM Tris buffer containing 0.5 M NaCl, 1 mM MnCl 2 , 1 mM CaCl 2 , and 1 mM MgCl 2 , pH 7.4, and loaded with a pool of plasma samples (6.84 mg protein). The flow-through plasma, consisting of plasma free of Lh and Fsh, was stored at À208C until use. Con A-bound GTHs were eluted with 10 mM methyl a-D-glucopyranoside and 300 mM methyl a-D-mannopyranoside.
Production and Purification of Recombinant European Sea Bass Fshb
To generate specific polyclonal antibodies, recombinant Fshb was produced using the Bac-to-Bac baculovirus expression system as described previously by Molés et al. [22] . Briefly, a cDNA fragment containing the open reading frame of European sea bass fshb and a C-terminal 63His tag were obtained by PCR using specific primers. The cDNA was directionally cloned into donor plasmid pFastBac1 and used to generate recombinant baculovirus by transposition. The baculovirus-Fshb was used to infect insect cells derived from the fall armyworm Spodoptera frugiperda (Sf9). The Sf9 cells were grown at 288C in Sf-900 II SFM medium (Invitrogen), containing 100 U ml À1 penicillin and 100 lg ml À1 streptomycin (Invitrogen). Monolayer cultures of Sf9 cells were grown to 80%-85% of confluence (roughly 12 3 10 6 cells) and later infected at a multiplicity of infection of 3 pfu (plaque-forming units) ml À1 during 4-5 days. Cells and medium were then harvested by centrifugation (110 3 g, 10 min) and stored at À808C until used. The infected cells were resuspended in lysis buffer (50 mM Tris-HCl, pH 8.0, 100 mM KCl, 1% Nonidet P-40, 1 mM PMSF, and 1 lg ml À1 aprotinin), and their cell membranes were disrupted by brief periods of sonication on ice using a cell disrupter (Vibracell; Sonics & Materials, Inc.). Supernatants containing soluble proteins were recovered after removal of cell debris by centrifugation at 35 000 3 g for 30 min at 48C.
Recombinant Fshb from supernatants of Sf9 cell lysates was purified by immobilized metal affinity chromatography (IMAC Ni 2þ ) using His GraviTrap prepacked columns (GE Healthcare) according to the manufacturer's instructions. Briefly, the pH of the supernatant was adjusted to 7-8 with diluted acetic acid, and the prepacked columns were equilibrated with PBS (20 QUANTITY AND BIOACTIVITY OF EUROPEAN SEA BASS Fsh mM sodium phosphate and 500 mM NaCl, pH 7.4) containing 20 mM imidazole. After loading the supernatants, three washes with PBS containing 20, 70, and 100 mM imidazole, respectively, were performed. The bound Fshb was eluted with PBS containing 500 mM imidazole. The purity of fractions obtained was analyzed by SDS-PAGE and Western blot.
A second purification step was performed consisting of a protein extraction from the SDS-PAGE by passive elution. Proteins obtained by the IMAC purification were separated by a SDS-PAGE (11%) under reducing conditions (5% 2-mercaptoethanol). The gel was stained with a negative and reversible protein stain for polyacrylamide gels (E-Zinc Stain; PIERCE), and the band corresponding to Fshb was excised. Individual slices were placed in microcentrifuge tubes and protein was extracted from the gel by passive elution in 0.1-0.2 ml band À1 of buffer (50 mM Tris-HCl, 150 mM NaCl, and 0.1 mM ethylenediaminetetraacetic acid, pH 7.5) following a method adapted from the Pierce technical resource (TR0051.0). The tubes were incubated overnight at 48C followed by 2-h incubation at 258C in rotary shaker (300 rpm). Finally, a centrifugation at 10 000 3 g for 10 min at 48C was performed, and the supernatants stored at À808C. Protein purity was confirmed by SDS-PAGE (15%) and staining with Coomassie brilliant blue.
Western Blot Analysis
The proteins separated by SDS-PAGE were transferred to polyvinylidene fluoride (PVDF) membranes (Immobilon P; Millipore). The membranes were blocked overnight with 5% skimmed milk at 48C, incubated for 90 min at room temperature with anti-63His (1:6000) (monoclonal antibody/HRP [horseradish peroxidase] conjugate; Clontech) or anti-mummichog Fshb (anti-mFshb) (1:3500), already validated for European sea bass Fshb [21] , washed, and incubated with 1:2000 goat anti-rabbit immunoglobulin G (IgG) HRP conjugate (GAR-HRP; Bio-Rad) for 60 min at room temperature. The immunodetection was performed by chemiluminescence (Western Blotting Luminol Reagent; Santa Cruz Biotechnology, Inc.) using the Versadoc image system (Bio-Rad).
European Sea Bass Fshb Antibody Production
Polyclonal antibodies against the purified recombinant Fshb were produced by a commercial company (Agrisera). Two rabbits were immunized with 60 lg of Fshb in Freund complete adjuvant by subcutaneous injection. Four subsequent immunizations were carried out with 25 lg of antigen in Freund incomplete adjuvant at 3-wk intervals. Rabbits were bled 2 wk before immunizations (preimmune serum) and 2 wk after immunizations III, IV, and V in order to perform the corresponding titration test. Final bleeding was done at 2 wk after the fifth immunization.
Immunological Determination of European Sea Bass Fsh
A dot-blot immunoassay was developed for immunological determination of Fsh. The sample preparations (1/50-1/250 pituitary extracts) were previously denatured (5% 2-mercaptoethanol, 4 min at 958C) and immobilized on a PVDF membrane using a Bio-Dot microfiltration apparatus (Bio-Rad). The membrane was blocked overnight with 5% skimmed milk in TBS-T at 48C, incubated with the anti-European sea bass Fshb produced (anti-sbsFshb) (1/2000) for 90 min at room temperature, washed, and incubated with GAR-HRP (1/1000) for 60 min at room temperature. The immunodetection was performed by chemiluminescence as described above. All the samples were measured in duplicate. Immunoreactivity signal (intensity (mm 2 ) À1 ) was calculated for each dot and compared to those obtained from serial dilutions of standard using the image analysis software Quantity One v 4.4 (Bio-Rad). Known quantities of purified native European sea bass Fsh [21] were used to generate the standard curve. After logarithmic transformation, the standard curve was linearized, and a concentration could be extrapolated for each sample analyzed.
Pituitary European Sea Bass Lh Measurements
Levels of Lh in pituitary were measured by homologous competitive ELISA according to Mateos et al. [34] . The sensitivity of the assay was 0.65 ng ml À1 (Bi/Bo 80%), and the intra-and interassay coefficients of variation were 11.7% and 11%, respectively.
Immunohistochemistry
In order to locate the gonadotroph cells in the pituitary, an immunohistochemistry was performed. Two-year-old sexually mature male and 3-yr-old mature female European sea bass were anesthetized in 0.1% (2)-phenoxyethanol (Merck) and then transcardially perfused with a fixative solution (4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.4). The brains were carefully extracted with the pituitary attached and postfixed overnight at 48C, dehydrated, and embedded in paraffin. Before immunostaining, 6-lm transversal sections were deparaffinized and washed in TBS-T (0.1% Triton X-100, used in this section) for 10 min. Endogenous peroxidase activity was blocked with 1% H 2 O 2 in TBS-T for 30 min. For epitope unmasking, samples were warmed at 908C-958C in 0.01 M sodium citrate buffer (pH 6) for 10 min and left to temper at room temperature for 15 min. Sections were saturated with 3% goat serum (Sigma-Aldrich) in TBS-T for 45 min in order to reduce the nonspecific reactions. They were then incubated with rabbit anti-sbsFshb (1/ 500) or anti-European sea bass Lhb (anti-sbsLhb) (1/1000) [34] overnight at room temperature. Sections were rinsed three times with TBS-T for 10 min and were incubated with GAR-HRP (1/200) for 100 min. Finally, sections were rinsed with TBS-T (2 3 10 min) and 0.05 M Tris-HCl (pH 7.6) (1 3 10 min), and peroxidase activity was visualized by treatment with 0.025% (w/v) 3,3 0 -diaminobenzidine tetrahydrochloride and 0.01% (v/v) H 2 O 2 in 0.05 M TrisHCl buffer (pH 7.6) for 5-15 min. The sections were then rinsed, counterstained with hematoxylin (25%), dehydrated in ethanol, cleared in xylene, and cover slipped with DPX mounting medium (Panreac).
The immunostained sections were observed under a light microscope (Nikon Elipse) and were photographed digitally. The specificity of the immunoreaction was confirmed by incubating the sections with preimmune rabbit serum instead of the specific anti-sbsFshb (data not shown).
Data Representation and Statistical Analysis
Because of the different concentrations obtained according to the assay used, the Fsh levels have been expressed as relative values for a better understanding and comparison of the results. The 200 dph males exhibiting the first histological signs of gonadal differentiation [31] were chosen as the reference group to study the Fsh profile during the sex differentiation period. To study the Fsh profile of females during oogenesis, the samples were grouped according to the ovarian stage of development (see Experimental Animals and Sample Collection), and evtg females were chosen as the reference group. The Fsh levels of these reference groups were set as 1. Statistical significance of the differences between group means of hormone levels or receptor activation (luciferase activity) was determined by one-way ANOVA followed by the Holm-Sidak method using SigmaStat 3.5 (Systat Software Inc.). When the test of equal variance failed, ANOVA on ranks (Kruskal-Wallis) was performed followed by a pair-wise multiple comparison procedure (i.e., the Dunn method). The correlation coefficients between the two assays were calculated using the Pearson product moment test. Data are presented as mean 6 SEM.
After conversion of the results to relative levels, the pituitary Fsh biological to immunological (B:I) ratio was calculated by dividing the pituitary values obtained from the bioassay by those from the immunoassay.
RESULTS
Development and Validation of the European Sea Bass Fsh Bioassay
Previous studies have shown that the sbsFshr/pCRE-LUC HEK293 stable clone expressed the luciferase gene in a dosedependent manner when stimulated with European sea bass Fsh [21, 22] . Because stimulation of luciferase activity declines with time, the luminescent signal was monitored over time after treatment with Fsh. Incubation of sbsFshr/pCRE-LUC HEK293 cells with a single dose of recombinant CHO-scFsh for 3, 6, 9, 15, 20, or 24 h showed maximum stimulation between 6 and 9 h (data not shown). A 6-h incubation period was used for all further studies.
The Fsh specificity of the sbsFshr cell line was examined previously by the addition of recombinant European sea bass Lh and other heterologous gonadotropins [22] . Dilutions of the recombinant Fsh (CHO-scFsh and Sf9-Fsh), pituitary extracts, and plasma samples were tested in the luciferase assay system. All of them stimulated the sbsFshr in a dose-dependent manner, similar to the native Fsh standard curve (Fig. 1A) . To detect potential nonspecific plasma effects in the rise of intracellular cAMP, receptor activation with Con A-treated plasma was analyzed, and no activation was detected (Fig. 1B) .
The sensitivity of the bioassay, defined as the lowest concentration of Fsh able to stimulate a luciferase activity higher
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. The intraassay coefficient of variation (CV), calculated by measuring replicates of the same sample (n ¼ 14) within the assay, was estimated at 9.3%. The interassay CV, calculated by measuring replicates of the same sample in different assays (n ¼ 10), was 10.9%.
Development and Validation of European Sea Bass Fsh Dot-Blot Immunoassay
In order to generate antibodies against European sea bass Fshb and develop a specific immunoassay, recombinant Fshb was produced using the baculovirus expression system. In this system, recombinant Fshb remained inside the infected cells instead of being secreted [22] . Therefore, recombinant Fshb was purified from cell lysates by affinity chromatography (IMAC Ni 2þ ). Analysis by SDS-PAGE and Western blot with anti-63His (data not shown) and anti-mFshb confirmed the identity and abundance of Fshb in the obtained fractions (Fig.  2, A and B) . However, the Coomassie blue stain showed the presence of high molecular weight proteins in addition to Fshb ( Fig. 2A) and, thus, another step of purification was necessary to obtain a satisfactory degree of purity. Due to its excellent ability to resolve individual components of protein mixtures, SDS-PAGE was used as an added step in the purification process. Finally, after protein extraction by passive elution, a high degree of antigen purity was achieved (Fig. 2C) .
Polyclonal antibodies against European sea bass Fshb were obtained by rabbit immunizations using this purified protein.
The antibodies reacted strongly and specifically with Fshb under reducing conditions; however, a very weak reaction was obtained under nonreducing conditions (Fig. 3, A and B) . Therefore, a dot-blot immunoassay was developed for Fsh determination in denatured samples. Validation of the assay was performed only for pituitary samples because the plasma Fsh concentrations were below or near the limit of detection. The sensitivity of the immunoassay, defined as the lowest dose of Fsh able to increase a dot density higher than the mean plus twice the standard deviation of zero dose of Fsh (basal), was 162.8 ng ml À1 . Dose-response curves of pituitary extracts and recombinant Fsh (Sf9-Fsh) were similar to the standard curve of native purified Fsh. No cross-reactivity was detected with serial dilutions of recombinant Lh (Fig. 4) . The intraassay CV, calculated by measuring replicates of the same sample within the assay (n ¼ 10), was estimated at 9.8%. The interassay CV, calculated by measuring replicates of the same sample in different assays (n ¼ 8), was 11.5%. 
QUANTITY AND BIOACTIVITY OF EUROPEAN SEA BASS Fsh
Determination of Fsh Levels During Sex Differentiation and the Reproductive Cycle
The assays developed in this study were used to analyze the profiles of Fsh in pituitary extracts and plasma samples from male and female sibling populations during sex differentiation, specifically from 150 to 300 dph. The quantity and bioactivity profiles of pituitary Fsh were very similar, showing high coefficient of correlation both in males and females (Fig. 5A) , nevertheless the absolute concentrations calculated by immunoassay were always higher than by bioassay. Relative values, with respect to males at 200 dph, were used to plot the profiles of pituitary and plasma Fsh during this period. At 200 dph, the mean content, relative to the standard, of pituitary Fsh in males as measured by the immunoassay was 6.04 lg whereas the bioactivity was equal to 0.87 lg. At this sampling point, the plasma Fsh bioactivity was equal to 216 ng ml À1 of standard. ). Different letters indicate significant differences over time for female or male populations (capital letters for immunoassay and lowercase letters for bioassay). Asterisks (bioassay) and plus signs (immunoassay) indicate significant differences between the two populations at equivalent sampling points. Note: statistics at 200 dph in immunoassay is denoted as AB in males and A in females.
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Relative levels showed that the bioactivity increased much more than the quantity found in the reference group, for example, while the bioactivity increased ;16-fold, the amount of Fsh increased only ;6-fold in females at 300 dph (Fig. 5B) . At 150 dph, pituitary Fsh levels were very low in both sexes and increased significantly beginning at 200-250 dph (Fig.  5B) . During the period studied, the Fsh levels tended to be higher in females than in males, regardless of the assay used. Moreover, the B:I ratio was higher in females than males ( Table 1 ). The profile of plasma Fsh bioactivity was completely opposite to those of the pituitary, and in both sexes, Fsh levels were higher at 150 dph than at 300 dph (Fig. 5C ). As observed in the pituitary, there was a tendency for plasma Fsh levels to be higher in females than males.
Similar to the study during sex differentiation, a high coefficient of correlation was obtained in the determination of the quantity and bioactivity of Fsh during the reproductive cycle of adult females (Fig. 6A) . As seen above, the absolute concentrations calculated by the immunoassay were always higher than for the bioassay, and the Fsh profiles were plotted relative to levels in evtg females. In this stage (evtg), the mean content of pituitary Fsh as measured by immunoassay was 71.01 lg whereas the bioactivity was equal to 12.14 lg of standard. The plasma Fsh bioactivity was equal to 4.03 ng ml À1 of standard. The quantity and bioactivity relative levels of pituitary Fsh increased during evtg, peaked in lvtg-pvtg until mat-ovul, and finally tended to decline in the atre stage (Fig. 6B) . The Fsh B:I ratio decreased throughout the cycle (Table 1) . Concurrently, pituitary ). Different letters indicate significant differences between developmental stages (capital letters for immunoassay and lowercase letters for bioassay).
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Lh levels had an identical profile to that of Fsh (Fig. 6C) . In the plasma, the Fsh bioactivity levels increased during evtg, peaked in lvtg-pvtg, and decreased in the mat-ovul stage (Fig. 6D) .
Immunohistochemistry
The antibodies against European sea bass Fshb or Lhb were used to differentially stain the pituitary gonadotropin producing cells of sexually mature male. Two different GTH cell populations expressing Fsh and Lh were observed (Fig. 7) . The Fsh cells were distributed throughout the whole proximal pars distalis (PPD), isolated or arranged in small groups (Fig.  7A) . Conversely, Lh formed strands or compact groups (Fig.  7B ) distributed mostly in the ventral part of the PPD and surrounding the pars intermedia and were more numerous than Fsh cells. The same results were observed in a pituitary of a sexually mature female (data not shown).
DISCUSSION
The present study reports, for the first time in a fish with group-synchronous ovarian development, the monitoring of the Fsh levels during critical moments of the reproductive life cycle using a newly developed bioassay and an immunoassay. The immunological determinations of Fsh, based on antigenantibody reaction, do not necessarily reflect the biological signal perceived by its cognate receptor [24] . Consequently, an in vitro bioassay for Fsh constitutes an ideal approach to determine functional aspects of this GTH. The bioassay developed here, using cotransfection of sbsFshr cDNA and a luciferase reporter gene in HEK 293 cells, exhibited dosedependent receptor activation and was able to measure the bioactivity of European sea bass Fsh with a high degree of sensitivity and specificity. In fish, receptor transactivation systems that were transiently transfected or stable lines have been used to investigate functional specificity of the receptor/ hormone interactions using recombinant or native fish GTHs [9] . However, our homologous Fsh bioassay is the first one developed and validated in fish to measure Fsh bioactivity in pituitary and plasma samples. The bioassay showed optimal characteristics of precision, specificity, and sensitivity, in concordance with those reported for other FSH bioassays in mammals [35] .
Traditionally, the immunoassays developed to determine GTH levels in fish have been radioimmunoassays or ELISAs based on native GTHs subunits purified from fish pituitaries and their specific antibodies. Native Fsh purification is a highly demanding process as regards time and cost, and substantial amounts of pituitary glands are required, which often limits the production of specific antibodies [9] . In the present study, recombinant Fshb was produced using a baculovirus expression system. The production yield was high, but Fshb was undetectable in the culture medium because most of the recombinant subunit was found in the cell lysate. The recombinant Fshb was isolated after a two-step purification from cell lysates and was used to produce polyclonal antibodies, which exhibited a strong reaction under reducing conditions but a very weak reaction under native conditions. There is no clear explanation for this observation, but we could hypothesize that denaturation of the antigen during the purification process led to a different conformation from the native subunit that could have been crucial in the generation of antibodies that recognize mainly internal epitopes of the subunit. This explanation could account for the observed differences in reactivity under reducing versus native conditions. Despite this, a specific dot-blot immunoassay able to measure European sea bass Fsh in pituitary was developed. This assay did not show cross-reactivity with European sea bass Lh and showed low intra-and interassay CVs, comparable to those reported for other fish Fsh immunoassays [3, 6, 8] .
Studies in mammals have shown a relative abundance of intrapituitary and circulating isoforms of GTHs that differ from each other not only in their carbohydrate composition, but also in their ability to remain in the blood stream and in their biopotency, provoking a range of biological responses in vitro and in vivo [25] . Also, it is known that in experimental animals as well as in humans a close relationship exists between the functional state of the gonad and the presence of a particular isoform pattern in the pituitary and in the circulation [25, 27, 36] . Based on the assumption that immunoreactivity is a measure of the quantity of Fsh and that bioactivity provides information relative to the ability to elicit a biological response, the B:I ratio should provide an assessment of the average quality of individual Fsh molecules in a biological sample at a given time. Therefore, the two methods are different but complementary, and their combination allows the evaluation of the relative bioactivity of defined amounts of Fsh according to the biological stage of the animal. 
854
The pituitary Fsh profiles of European male and female sea bass during sex differentiation and during the female reproductive cycle obtained with the immunoassay were similar to those obtained with the bioassay. However, the calculated concentrations (absolute values) were always higher with the immunoassay (Figs. 5A and 6A) . One possible explanation could be related to the biopotency of the Fsh variant used as standard because, in the bioassay, a more potent standard than the samples would result in an extrapolation of lower levels of concentration. Also, the immunoassay recognizes Fshb and does not distinguish between dimers (alphabeta) or monomers (beta), whereas the bioassay measures only the bioactive dimers (alpha-beta).
The first histological signs of gonadal differentiation were observed around 150 dph in females and 200 dph in males, which coincided with the time that sex differentiation of the ovary and testes, respectively, was well underway [31] . At 250 dph, gonads were completely differentiated in females and males. In both sexes, plasma Fsh bioactivity levels were high at 150-200 dph and progressively decreased by 300 dph. In the pituitary, the profiles of Fsh quantity and bioactivity were exactly the opposite, increasing from 150-200 dph to 300 dph. These results indicate that high levels of Fsh could be required at initial stages of sexual differentiation. Thus, the data obtained suggest a high Fsh release in plasma at early stages followed by a later accumulation in the pituitary. In this regard, previous studies performed on the same animals and during the same period showed that the maximum levels of fshb and cga pituitary expression were achieved at 200 dph and remained high until 300 dph; in addition, both were higher than lhb. Moreover, plasma levels of Lh were low at the early stages, with an elevation only observed at 250 dph when the gonads were completely differentiated in both sexes [19] . On the other hand, the immunohistochemical analysis in this study revealed that, as in other teleost species [16, [37] [38] [39] [40] , Fsh and Lh in European sea bass are produced in different cell populations of the adenohypophysis. Moreover, in rainbow trout (Oncorhynchus mykiss), platyfish (Xiphophorus maculatus), and acará (Cichlasoma dimerus), it has been reported that the Fsh cells appeared prior to the onset of sexual differentiation, while Lh cells were observed several days after this process started or upon its completion [12, 14, 15, 17] . Taken together, these data support a key role for Fsh during sex differentiation. Additionally, both plasma and pituitary European sea bass Fsh levels were higher in females than in males, and the pituitary B:I ratio during this period was also higher in females, suggesting a possible sexual dimorphism in the synthesis and potency of Fsh during sex differentiation of European sea bass. Expression analysis of cytochrome P450 aromatase genes in the ovary (cyp19a1) and brain (cyp19a2) in the same fish populations and period [20, 41] showed that females exhibited higher expression levels than males, suggesting that the high levels of Fsh seen in this study could be involved in the control of their expression. The enzyme Cyp19a1 catalyzes the conversion of testosterone into E2, and previous studies have demonstrated a direct stimulation of cyp19a1 expression by Fsh in fish oocytes [42] .
Regarding the annual cycle of sexually mature females, the Fsh quantity and bioactivity levels in the pituitary were significantly higher during lvtg-pvtg and mat-ovul, with a tendency to decrease at the stage of atre at the end of the reproductive season. In the plasma, Fsh bioactivity levels peaked at lvtg-pvtg and declined gradually thereafter. This Fsh profile is concordant with those found in synchronous species. In coho salmon, Swanson [43] reported that plasma Fsh concentration increased during vitellogenesis, with the highest levels occurring during mid-to late vitellogenesis, after which plasma Fsh decreased as ovulation approached. In rainbow trout, plasma Fsh levels increased significantly at the onset of vitellogenesis [44] , being maintained during active vitellogenesis and decreasing prior to maturation [45] . On the other hand, when the pituitary content of European sea bass Lh was analyzed in the same female cycle samples, the quantity profile turned out to be identical to that of Fsh. Previously, in the same animals, the Lh and E2 plasma levels and gene expression of fshr, lhr, and cyp19a1 were analyzed [23] . Correlation between lhr receptor expression and its ligand levels was observed, with Lh plasma levels and lhr gene expression peaking at mat-ovul, whereas fshr gene expression exhibited very high levels at lvtgpvtg coincident with the highest plasma levels of Fsh bioactivity (Rocha et al. [23] and this study, respectively). At mat-ovul, fshr gene expression remained elevated, and plasma Fsh bioactivity levels decreased although not significantly. The high levels of fshr expression in the ovary [23] and the Fsh content in pituitary and bioactivity in plasma (this study) during maturation could be explained by the reproductive strategy of this species. European sea bass ovary exhibits a group-synchronous type of development and contains clutches of oocyte populations at various stages of secondary growth that are successively recruited for maturation [32, 46] . Therefore, during the maturation stage, Fsh would be needed by clutches of oocytes that are still in vitellogenesis. The data presented here indicate similar synthesis and accumulation of Fsh and Lh in the pituitary gland but differences in the release to the bloodstream. Moreover, the maximum plasma FSH bioactivity observed here coincided with the maximum expression of cyp19a1 and E2 plasma levels reported earlier [23] . Estradiol is known to stimulate the hepatic synthesis of vitellogenin, which is then incorporated progressively into the growing oocytes during the period of gametogenesis [47] . Several studies have demonstrated that Fsh stimulates in vitro production of E2 in ovarian explants or isolated vitellogenic follicles [21, 42, 48, 49] and promotes the incorporation of vitellogenin into the oocytes [50, 51] . Therefore, according to the present results, it appears that in the European sea bass Fsh regulates vitellogenesis by stimulation of the ovarian production of E2 via activation of Cyp19a1, whereas Lh would be responsible for the final events, such as oocyte maturation and ovulation.
In the pituitary of adult female European sea bass, the B:I ratio decreased as ovarian recrudescence progressed whereas the opposite occurred during sex differentiation. This observation was true for both ratios calculated from absolute values and relative values, which maintained their proportions between the two experiments. This could suggest the presence of Fsh isoforms in the pituitary with different biopotencies associated with the reproductive stage of the animal. Studies in mammals have demonstrated that changes in the content of sialic acid affect the bioactivity of FSH isoforms. In humans, less acidic FSH isoforms exhibit higher B:I ratios than their more acidic counterparts [52] . In rats, it has also been suggested that more sialylated FSH isoforms are less biopotent whereas less acidic isoforms exhibit higher biopotency but shorter half-life in circulation [36] . Besides, it seems that intrapituitary FSH molecular microheterogenity may change depending on the age, sexual development, and/or the steroidogenic milieu [36, 53] . Our results seem to indicate that during sex differentiation Fsh isoforms with higher potency are needed, whereas less biopotent but possibly long-lived Fsh could be needed as ovarian growth progresses in adult females.
QUANTITY AND BIOACTIVITY OF EUROPEAN SEA BASS Fsh
In conclusion, two homologous and specific assays have been developed to measure European sea bass Fsh levels in the plasma and pituitary. The assays have provided, for the first time in a fish species, quantitative and qualitative information on Fsh in critical moments of the reproductive life cycle. The obtained results reinforce the hypothesis that Fsh has an important role during sex differentiation of European sea bass. In addition, a sexual dimorphism in the synthesis and potency of Fsh is suggested. On the other hand, in adult females, a less biopotent form of Fsh than that found during sex differentiation could regulate secondary oocyte growth (vitellogenesis), while Lh would be responsible for the final reproductive events, such as oocyte maturation and ovulation.
